144 related articles for article (PubMed ID: 24182682)
1. [Interferon dysoric retinopathy in chronic viral hepatitis C: case report and literature review].
Naïja N; Mohsni B; Belkahla N; Maamouri N; Ben Mami N
Rev Med Interne; 2014 Aug; 35(8):543-5. PubMed ID: 24182682
[TBL] [Abstract][Full Text] [Related]
2. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
[TBL] [Abstract][Full Text] [Related]
3. Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis.
Kang HY; Shin MC
Korean J Ophthalmol; 2012 Apr; 26(2):147-50. PubMed ID: 22511844
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
Adams S; Ostermeier M
Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
[TBL] [Abstract][Full Text] [Related]
5. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Burgueño-Montañés C; Pérez-Álvarez R
Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
Novelli FJ; Przysiezny A; Rosa EL; Garcia RF; Nóbrega MJ
Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
Tsolakos A; Zalatimo N
Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
[TBL] [Abstract][Full Text] [Related]
9. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
[TBL] [Abstract][Full Text] [Related]
11. [Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
Sandner D; Pillunat LE
Klin Monbl Augenheilkd; 2004 Jan; 221(1):63-6. PubMed ID: 14745683
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Kim ET; Kim LH; Lee JI; Chin HS
Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
Vujosevic S; Tempesta D; Noventa F; Midena E; Sebastiani G
Hepatology; 2012 Aug; 56(2):455-63. PubMed ID: 22331668
[TBL] [Abstract][Full Text] [Related]
14. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
Hara K; Tanito M; Ohira A
Acta Ophthalmol; 2012 Mar; 90(2):e158-60. PubMed ID: 21649866
[No Abstract] [Full Text] [Related]
15. Hepatitis C and interferon-associated retinopathy: a case report.
Van Wie AM
Optometry; 2011 Dec; 82(12):739-43. PubMed ID: 22108545
[TBL] [Abstract][Full Text] [Related]
16. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.
Goncalves LL; Farias AQ; Gonçalves PL; D'Amico EA; Carrilho FJ
World J Gastroenterol; 2006 Jul; 12(28):4602-3. PubMed ID: 16874884
[TBL] [Abstract][Full Text] [Related]
17. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Schulman JA; Liang C; Kooragayala LM; King J
Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
[TBL] [Abstract][Full Text] [Related]
18. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
19. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Moisseiev E; Goldenberg D; Kurtz S
Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
[TBL] [Abstract][Full Text] [Related]
20. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
